Your browser is no longer supported. Please, upgrade your browser.
BiondVax Pharmaceuticals Ltd.
Index- P/E- EPS (ttm)-3.24 Insider Own37.10% Shs Outstand10.84M Perf Week34.05%
Market Cap48.38M Forward P/E- EPS next Y-6.00 Insider Trans0.00% Shs Float0.18M Perf Month35.71%
Income-34.30M PEG- EPS next Q- Inst Own4.10% Short Float- Perf Quarter-89.33%
Sales- P/S- EPS this Y0.40% Inst Trans0.22% Short Ratio- Perf Half Y-91.01%
Book/sh-1.80 P/B- EPS next Y-9900.00% ROA- Target Price- Perf Year-57.37%
Cash/sh1.10 P/C3.97 EPS next 5Y- ROE209.00% 52W Range2.35 - 62.00 Perf YTD55.52%
Dividend- P/FCF- EPS past 5Y-19.00% ROI- 52W High-93.18% Beta2.42
Dividend %- Quick Ratio6.50 Sales past 5Y- Gross Margin- 52W Low80.00% ATR0.42
Employees17 Current Ratio6.50 Sales Q/Q- Oper. Margin- RSI (14)55.82 Volatility19.14% 10.75%
OptionableNo Debt/Eq- EPS Q/Q46.60% Profit Margin- Rel Volume1.07 Prev Close4.37
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume1.36M Price4.23
Recom- SMA2028.45% SMA5031.20% SMA200-80.18% Volume1,451,195 Change-3.20%
Oct-23-20 05:03PM  
Oct-02-20 06:00AM  
Aug-31-20 06:15AM  
Aug-20-20 04:01PM  
Aug-13-20 04:01PM  
Jul-01-20 06:00AM  
Jun-30-20 04:01PM  
Jun-16-20 08:57AM  
Jun-12-20 08:00AM  
Jun-10-20 07:00AM  
May-20-20 06:30AM  
May-09-20 08:47AM  
May-04-20 06:30AM  
Mar-24-20 04:01PM  
Mar-19-20 07:15AM  
Feb-05-20 01:00PM  
Jan-16-20 03:05PM  
Dec-04-19 08:25AM  
Nov-26-19 07:00AM  
Nov-18-19 07:15AM  
Nov-11-19 08:14AM  
Oct-07-19 09:15AM  
Aug-28-19 07:45AM  
Aug-01-19 10:00AM  
Jul-16-19 07:30AM  
Jul-08-19 05:45AM  
Jun-26-19 10:51AM  
Jun-25-19 09:37AM  
Jun-18-19 06:30AM  
Jun-12-19 03:30PM  
Jun-10-19 08:18AM  
May-30-19 07:10AM  
May-13-19 07:00AM  
Apr-30-19 04:01PM  
Apr-22-19 08:10AM  
Apr-17-19 01:00PM  
Apr-15-19 07:50AM  
Mar-28-19 07:30AM  
Mar-21-19 07:00AM  
Nov-28-18 07:40AM  
Nov-26-18 07:00AM  
Nov-20-18 11:00AM  
Nov-19-18 07:00AM  
Nov-13-18 04:01PM  
Oct-24-18 07:00AM  
Oct-22-18 08:00AM  
Oct-17-18 08:15AM  
Sep-05-18 09:30AM  
Sep-04-18 06:15AM  
Aug-22-18 07:00AM  
Aug-20-18 07:50AM  
Aug-14-18 06:00AM  
Aug-08-18 08:30AM  
Jun-28-18 07:00AM  
Jun-19-18 09:00AM  
Jun-05-18 07:45AM  
Jun-01-18 10:30AM  
May-29-18 07:00AM  
May-07-18 09:45AM  
Apr-30-18 04:05PM  
Apr-13-18 07:20AM  
Apr-12-18 06:30AM  
Apr-11-18 07:45AM  
Apr-09-18 08:15AM  
Mar-15-18 08:25AM  
Mar-13-18 09:00AM  
Feb-08-18 08:30AM  
Jan-02-18 09:00AM  
Dec-27-17 09:00AM  
Dec-12-17 12:00PM  
Dec-11-17 07:30AM  
Dec-05-17 09:00AM  
Nov-28-17 09:00AM  
Nov-20-17 09:00AM  
Sep-20-17 01:00PM  
Sep-18-17 11:35AM  
Sep-13-17 08:25PM  
Sep-12-17 07:15AM  
Aug-31-17 07:30AM  
Aug-14-17 08:00AM  
Aug-01-17 01:00PM  
Jul-20-17 06:30AM  
Jul-18-17 07:30AM  
Jul-06-17 01:00PM  
Jun-28-17 04:01PM  
Jun-19-17 07:00AM  
Jun-12-17 08:15AM  
Jun-02-17 01:00PM  
May-30-17 07:00AM  
May-08-17 03:00PM  
Apr-28-17 08:00AM  
Mar-30-17 11:59AM  
Mar-13-17 09:30AM  
Jan-20-17 11:30AM  
BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company, focuses on developing and commercializing immunomodulation therapies for infectious diseases primarily in Israel. Its product candidate is M-001, a synthetic peptide-based protein, which is in Phase III clinical trials for treatment of seasonal and pandemic strains of the influenza virus. The company was founded in 2003 and is headquartered in Jerusalem, Israel.